Kiran Somvanshi

Stories by the author

• India Inc's 12 companies managed to grow by at least 15% every quarter for last 5 years

  
  30 Apr 2012 02:20 AM IST
• Biocon: Parting ways with Pfizer may hurt company in long run

  
  14 Mar 2012 10:32 AM IST
• GSK Consumer Healthcare: Transfer of pricing pressure is the key

  
  07 Mar 2012 05:41 AM IST
• Unitech: Huge land bank is a positive for realty company

  
  28 Feb 2012 03:49 AM IST
• Ranbaxy Labs: USFDA issues, currency moves to shape future course

  
  24 Feb 2012 03:59 AM IST
• GSK Pharma: New launches, stronger field force could help

  
  22 Feb 2012 03:11 AM IST
• Nestle: Rising margins a positive, but competition seen as a threat

  
  16 Feb 2012 01:49 AM IST
• Dr Reddy's Labs: US, domestic business growth augurs well

  
  07 Feb 2012 02:04 AM IST
• Hindustan Unilever: Soaps in top foam, but faces real test after June

  
  07 Feb 2012 01:59 AM IST
• ET 500 2011: Innovation will be key to survival, says Glen Saldanha, Chairman & MD, Glenmark Pharma

  
  20 Dec 2011 08:01 AM IST
• ET 500 2011: We aim to sell 20-25m sq ft a year, says Pirojsha Godrej, ED of Godrej Properties

  
  20 Dec 2011 08:01 AM IST
• ET 500 2011: Lessons that India Inc has to offer on managing foreign acquisitions

  
  20 Dec 2011 08:01 AM IST
• ET 500 2011: Our goal is to be a Rs 10,000 crore company by 2020, says Ulhas Kamath, Deputy MD, Jyothy Labs

  
  20 Dec 2011 08:01 AM IST
• Sugar mills' EBITDA likely to fall to 4-6% on increase in cane SAP: Analysts

  
  09 Nov 2011 04:35 AM IST